13F Holdings
中文EN

CYH COMMUNITY HEALTH SYSTEMS INC

Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 1108109 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-7.8%
TTM net income YoY-89.1%
TTM EPS YoY-89.8%
Revenue 3-yr CAGR-2.2%
Net income 3-yr CAGR-46.5%

Margins

Gross margin85.5%
Operating margin10.9%
Net margin0.3%
FCF margin-1.0%
EBITDA margin14.6%

Returns

ROE—
ROA0.3%
ROIC (approx.)7.5%
Asset turnover0.92x

Leverage & solvency

Liabilities / assets107.7%
Debt / equity—
Current ratio1.48x
Interest coverage—

Cash quality & payout

Operating cash flow / net income5.86x
Accruals ratio-1.4%
Payout ratio—
Capex / revenue2.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$12.48B$12.63B$12.49B$12.21B$12.37B
Cost of revenue$1.86B$1.95B$1.99B$1.98B$2.04B
Gross profit$10.62B$10.69B$10.50B$10.24B$10.33B
Operating income$1.49B$542.00M$957.00M$821.00M$1.40B
Pretax income$724.00M-$283.00M$207.00M$349.00M$499.00M
Income tax$48.00M$79.00M$191.00M$170.00M$131.00M
Net income$509.00M-$516.00M-$133.00M$46.00M$230.00M
EBITDA$1.91B$1.03B$1.46B$1.35B$1.94B
EPS (basic)3.81-3.90-1.020.351.82
EPS (diluted)3.77-3.90-1.020.351.76
Weighted avg. shares (diluted)135.01M132.10M130.45M130.06M130.60M
Balance sheet
Cash & equivalents$260.00M$37.00M$38.00M$118.00M$507.00M
Receivables$2.08B$2.29B$2.23B$2.04B$2.06B
Current assets$3.23B$3.30B$3.21B$3.08B$3.48B
PP&E, net$4.50B$4.78B$5.21B$5.37B$5.55B
Goodwill$3.32B$3.79B$3.96B$4.17B$4.22B
Intangibles$7.00M$15.00M$20.00M$2.00M—
Total assets$13.20B$14.05B$14.46B$14.67B$15.22B
Current liabilities$2.21B$2.35B$2.14B$2.19B$2.36B
Short-term debt$16.00M$20.00M$21.00M$21.00M$31.00M
Long-term debt$10.38B$11.43B$11.47B$11.61B$12.11B
Total debt$10.40B$11.45B$11.49B$11.63B$12.14B
Total liabilities$14.04B$15.37B$15.28B$15.40B$16.03B
Shareholders' equity-$1.39B-$1.91B-$1.39B-$1.37B-$1.37B
Net debt$10.14B$11.41B$11.45B$11.52B$11.63B
Shares outstanding138.63M138.92M136.77M134.70M132.15M
Cash flow statement
Operating cash flow$543.00M$480.00M$210.00M$300.00M-$131.00M
Capital expenditure$335.00M$360.00M$467.00M$415.00M$469.00M
Free cash flow$208.00M$120.00M-$257.00M-$115.00M-$600.00M
Investing cash flow$847.00M-$275.00M-$26.00M-$259.00M-$524.00M
Financing cash flow-$1.17B-$206.00M-$264.00M-$430.00M-$514.00M
Depreciation & amortization$426.00M$486.00M$505.00M$534.00M$540.00M
Stock-based compensation$11.00M$17.00M$22.00M$20.00M$25.00M

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.